Market Place
Sourcing Support
Enforcement Report - Week of March 26, 2025
26 Mar 2025 //
FDA
Health Canada Issues Recalls of Sensipar`s cinacalcet
27 Feb 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Pharmascience
30 Dec 2024 //
HEALTH CANADA
Enforcement Report - Week of November 6, 2024
06 Nov 2024 //
FDA
Enforcement Report - Week of January 31, 2024
31 Jan 2024 //
FDA
Dr Reddy`s Labs launches generic Sensipar tablets
01 Oct 2020 //
PHARMABIZ
Dr. Reddy`s Laboratories Announces the Launch of Cinacalcet Tablets
01 Oct 2020 //
BUSINESSWIRE
Acme Labs Generic Cinacalcet HCl Receives Approval in US
21 May 2020 //
FDA
Accord Healthcare`s Generic Cinacalcet Receives Approval in Europe
15 Apr 2020 //
EMA
Return of Amgen-Alexion deal talk gets cheers from Wall Street
27 Aug 2019 //
FIERCE PHARMA
Amgen sales slide as copies dig into Sensipar, Neulasta
31 Jul 2019 //
FIERCE PHARMA
LUPIN LTD`s generic CINACALCET HYDROCHLORIDE Receives Approval in US
28 Jun 2019 //
FDA
Alkem Labs Generic Cinacalcet Hydrochloride Receives Approval in US
20 May 2019 //
FDA
Teva rolled its generic anyway—and then Amgen settled
04 Jan 2019 //
FIERCE PHARMA
Teva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl Product
03 Jan 2019 //
BUSINESSWIRE
Watson Labs Teva`s Generic Cinacalcet Hydrochloride Receives Approval in US
27 Dec 2018 //
FDA
EMA Assessment & Procedural Steps Taken for Mylan`s Generic cinacalcet HCl
09 Oct 2018 //
EMA
Senispar (cinacalcet hydrochloride) : Amgen vs. Emcure Pharmaceuticals
15 Sep 2018 //
PATENT LITIGATION
Amneal obtains non-infringement finding in Sensipar case
02 Aug 2018 //
LIFESCIENCE PREVIEW
Could Amgen soften the biosim blow with an Alexion buy?
16 Jul 2018 //
FIERCE PHARMA
Senispar® (cinacalcet hydrochloride): Amgen Inc. v. Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd.
29 Jun 2018 //
PATENT LITIGATION
Amgen faces one-two blow from Repatha, Sensipar competition
14 Mar 2018 //
FIERCE PHARMA
Aurobindo Pharma`s Generic Cinacalcet HCl Receives Approval In US
10 Mar 2018 //
FDA
Cipla’s Generic Cinacalcet HCl Receives Approval In US
10 Mar 2018 //
FDA
FDA Approves 2 Cinacalcet Hydrochloride Generics for HPT Market Competition
09 Mar 2018 //
MDMAG
FDA Approves First Generic Versions of Amgen’s Sensipar
08 Mar 2018 //
RAPS
Amgen comes up short in Sensipar lawsuit against FDA
22 Feb 2018 //
FIERCE PHARMA
FDA Cherry-Picking Record In Sensipar Case, Amgen Says
21 Sep 2017 //
LAW360
EU Approves Expanded Use Of Mimpara® Cinacalcet Secondary Hyperparathyroidism
31 Aug 2017 //
PR NEWSWIRE
Amgen Receives Positive CHMP Opinion To Expand Use Of Mimpara® (cinacalcet)
23 Jun 2017 //
PR NEWSWIRE
Sensipar® (Cinacalcet Hydrochloride): Amgen Inc. V. Piramal Healthcare Limited
09 Jun 2017 //
PATENT LITIGATION
Amgen Sues to Reverse FDA Denial of Pediatric Exclusivity for Sensipar
01 Jun 2017 //
GENENGNEWS
Teva Pharms Cinacalcet Hydrochloride Receives Tentative Approval In US
26 Apr 2017 //
FDA
NICE set to back Parsabiv for kidney disease complication
08 Mar 2017 //
PMLIVE
FDA approves Amgen’s parsabiv™, new treatment for secondary hyperparathyroidism
07 Feb 2017 //
MULTIVU
European Commission Approves Parsabiv
11 Nov 2016 //
PR NEWSWIRE
Anvisa approves unpublished generic for hyperparathyroidism and antiepileptic
16 May 2016 //
ANVISA
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
